title: Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.
abstract: Selective fluorescent β-lactam chemical probes enable the visualization of the transpeptidase activity of penicillin-binding proteins (PBPs) at different stages of bacterial cell division. To facilitate the development of new fluorescent probes for PBP imaging, we evaluated 20 commercially available β-lactams for selective PBP inhibition in an unencapsulated derivative of the D39 strain of Streptococcus pneumoniae. Live cells were treated with β-lactam antibiotics at different concentrations and subsequently incubated with Bocillin FL (Boc-FL; fluorescent penicillin) to saturate uninhibited PBPs. Fluorophore-labeled PBPs were visualized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and fluorescence scanning. Among 20 compounds tested, carbapenems (doripenem and meropenem) were coselective for PBP1a, PBP2x, and PBP3, while six of the nine penicillin compounds were coselective for PBP2x and PBP3. In contrast, the seven cephalosporin compounds tested display variability in their PBP-binding profiles. Three cephalosporin compounds (cefoxitin, cephalexin, and cefsulodin) and the monobactam aztreonam exhibited selectivity for PBP3, while only cefuroxime (a cephalosporin) was selective for PBP2x. Treatment of S. pneumoniae cultures with a sublethal concentration of cefuroxime that inhibited 60% of PBP2x activity and less than 20% of the activity of other PBPs resulted in formation of elongated cells. In contrast, treatment of S. pneumoniae cultures with concentrations of aztreonam and cefoxitin that inhibited up to 70% of PBP3 activity and less than 30% of other PBPs resulted in no discernible morphological changes. Additionally, correlation of the MIC and IC50s for each PBP, with the exception of faropenem, amdinocillin (mecillinam), and 6-APA, suggests that pneumococcal growth inhibition is primarily due to the inhibition of PBP2x.
authors.affiliation: Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, Indiana, USA.
authors.forename: Ozden
authors.initials: O
authors.lastname: Kocaoglu
authors.affiliation: Department of Biology, Indiana University, Bloomington, Indiana, USA.
authors.forename: Ho-Ching T
authors.initials: HC
authors.lastname: Tsui
authors.affiliation: Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, Indiana, USA Department of Biology, Indiana University, Bloomington, Indiana, USA.
authors.forename: Malcolm E
authors.initials: ME
authors.lastname: Winkler
authors.affiliation: Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, Indiana, USA Department of Chemistry, Indiana University, Bloomington, Indiana, USA carlsone@umn.edu.
authors.forename: Erin E
authors.initials: EE
authors.lastname: Carlson
mesh_terms: D000560:Amdinocillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015780:Carbapenems / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D000077726:Doripenem; D004591:Electrophoresis, Polyacrylamide Gel; D000077731:Meropenem; D046915:Penicillin-Binding Proteins / Q000378:metabolism*; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000378:metabolism*; D013845:Thienamycins / Q000494:pharmacology; D047090:beta-Lactams / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D002511:Cephalosporins; D046915:Penicillin-Binding Proteins; D013845:Thienamycins; D047090:beta-Lactams; D000077726:Doripenem; C107057:fropenem; D000077731:Meropenem; D000560:Amdinocillin
references.citation: Antimicrob Agents Chemother. 1999 May;43(5):1124-8
references.pmid: 10223924
references.citation: J Bacteriol. 1999 Jun;181(12):3852-6
references.pmid: 10368166
references.citation: J Biol Chem. 2005 Apr 22;280(16):15984-91
references.pmid: 15596446
references.citation: FEMS Microbiol Rev. 2006 Sep;30(5):673-91
references.pmid: 16911039
references.citation: J Bacteriol. 2007 Jan;189(1):38-51
references.pmid: 17041037
references.citation: Nat Protoc. 2008;3(2):163-75
references.pmid: 18274517
references.citation: FEMS Microbiol Rev. 2008 Mar;32(2):234-58
references.pmid: 18266856
references.citation: J Bacteriol. 2009 May;191(9):3024-40
references.pmid: 19270090
references.citation: Antimicrob Agents Chemother. 2009 May;53(5):2176-80
references.pmid: 19237649
references.citation: J Bacteriol. 2011 Aug;193(16):4166-79
references.pmid: 21685290
references.citation: Future Microbiol. 2012 Mar;7(3):395-410
references.pmid: 22393892
references.citation: Curr Opin Microbiol. 2012 Apr;15(2):194-203
references.pmid: 22280885
references.citation: Microb Drug Resist. 2012 Jun;18(3):314-21
references.pmid: 22455550
references.citation: ACS Chem Biol. 2012 Oct 19;7(10):1746-53
references.pmid: 22909777
references.citation: Front Cell Infect Microbiol. 2013;3:7
references.pmid: 23471303
references.citation: PLoS One. 2013;8(3):e58492
references.pmid: 23505518
references.citation: Cold Spring Harb Perspect Med. 2013 Jul;3(7). pii: a010215. doi: 10.1101/cshperspect.a010215
references.pmid: 23818515
references.citation: J Bacteriol. 2013 Oct;195(19):4342-54
references.pmid: 23873916
references.citation: Mol Microbiol. 2013 Dec;90(5):939-55
references.pmid: 24118410
references.citation: Environ Microbiol. 2013 Dec;15(12):3133-57
references.pmid: 23848140
references.citation: Curr Protoc Chem Biol. 2013;5(4):239-50
references.pmid: 24391095
references.citation: Mol Microbiol. 2014 May;92(4):733-55
references.pmid: 24655324
references.citation: Microb Drug Resist. 2014 Jun;20(3):215-21
references.pmid: 24773288
references.citation: Microb Drug Resist. 2014 Jun;20(3):250-7
references.pmid: 24841912
references.citation: Mol Microbiol. 2014 Oct;94(1):21-40
references.pmid: 25099088
references.citation: Antimicrob Agents Chemother. 2015 Jan;59(1):609-21
references.pmid: 25385114
references.citation: Antimicrob Agents Chemother. 2015 May;59(5):2785-90
references.pmid: 25733506
references.citation: Antimicrob Agents Chemother. 2000 Jun;44(6):1745-8
references.pmid: 10817747
references.citation: J Mol Biol. 2000 Jun 2;299(2):477-85
references.pmid: 10860753
references.citation: Science. 2001 Jul 20;293(5529):498-506
references.pmid: 11463916
references.citation: Antimicrob Agents Chemother. 2002 May;46(5):1273-80
references.pmid: 11959556
references.citation: Trends Biochem Sci. 2002 Sep;27(9):438
references.pmid: 12217513
references.citation: Nature. 1975 Apr 10;254(5500):516-7
references.pmid: 1091862
references.citation: Antimicrob Agents Chemother. 1979 Nov;16(5):533-9
references.pmid: 393164
references.citation: Antimicrob Agents Chemother. 1980 Mar;17(3):364-71
references.pmid: 7425601
references.citation: Antimicrob Agents Chemother. 1980 Oct;18(4):629-37
references.pmid: 7447421
references.citation: Antimicrob Agents Chemother. 1982 Jun;21(6):950-6
references.pmid: 6180685
references.citation: Annu Rev Biochem. 1983;52:825-69
references.pmid: 6351730
references.citation: J Gen Microbiol. 1987 Mar;133(3):755-60
references.pmid: 3309169
references.citation: Mol Microbiol. 1987 Nov;1(3):355-63
references.pmid: 3448464
references.citation: Antimicrob Agents Chemother. 1994 May;38(5):973-80
references.pmid: 8067779
references.citation: Trends Microbiol. 1994 Oct;2(10):372-80
references.pmid: 7850204
references.citation: Antimicrob Agents Chemother. 1996 Apr;40(4):829-34
references.pmid: 8849235
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13403-6
references.pmid: 9811812